Martin, Peter

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 1,685

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood

Lymphoma Diagnosis and TreatmentAdvanced Breast Cancer Therapies

Cited by 299

Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma

Chiron, D., Di Liberto, M., Martin, P., Huang, X., Sharman, J., Blecua, P., Mathew, S., Vijay, P., Eng, K., Ali, S., et al. (2014) · Cancer Discovery

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 273

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

Ruan, J., Martin, P., Shah, B., Schuster, S. J., Smith, S. M., Furman, R. R., Christos, P., Rodriguez, A., Svoboda, J., Lewis, J., et al. (2015) · New England Journal of Medicine

Lymphoma Diagnosis and TreatmentMultiple Myeloma Research and Treatments

Cited by 236

Characterization of ibrutinib-sensitive and -resistant mantle lymphoma cells

Ma, J., Lu, P., Guo, A., Cheng, S., Zong, H., Martin, P., Coleman, M., & Wang, Y. L. (2014) · British Journal of Haematology

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 90

Induction of prolonged early G1arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1

Chiron, D., Martin, P., Di Liberto, M., Huang, X., Ely, S., Lannutti, B. J., Leonard, J. P., Mason, C. E., & Chen-Kiang, S. (2013) · Cell Cycle

PI3K/AKT/mTOR signaling in cancerLymphoma Diagnosis and Treatment

Cited by 71

Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib

Song, Z., Lu, P., Furman, R. R., Leonard, J. P., Martin, P., Tyrell, L., Lee, F. Y., Knowles, D. M., Coleman, M., & Wang, Y. L. (2010) · Clinical Cancer Research

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 59

Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals

Frey, M. K., Fowlkes, R. K., Badiner, N. M., Fishman, D., Kanis, M., Thomas, C., Christos, P. J., Martin, P., Gamble, C., Balogun, O. D., et al. (2020) · Gynecologic Oncology

COVID-19 and healthcare impactsCOVID-19 Impact on Reproduction

Cited by 51

The feasibility, acceptability, and usability of telehealth visits

Sinha Gregory, N., Shukla, A. P., Noel, J. J., Alonso, L. C., Moxley, J., Crawford, A. J., Martin, P., Kumar, S., Leonard, J. P., & Czaja, S. J. (2023) · Frontiers in Medicine

Telemedicine and Telehealth ImplementationHealthcare Systems and Technology

Cited by 33

Microenvironmental Signatures Reveal Biological Subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) Distinct from Tumor Cell Molecular Profiling

Cerchietti, L., Inghirami, G., Kotlov, N., Svekolkin, V., Bagaev, A., Frenkel, F., Revuelta, M. V., Phillip, J. M., Cacciapuoti, M. T., Rutherford, S. C., et al. (2019) · Blood

Lymphoma Diagnosis and TreatmentViral-associated cancers and disorders

Cited by 7